54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 08
11:33 UTC
|
MFC
Manulife Financial
|
◎ Target | firm only | Outperform | C$67.00→ C$70.00+4.5% |
|
Aug 08
11:33 UTC
|
MFC
Manulife Financial
|
◎ Target | firm only | Sec→ r Outperform | C$61.00→ C$67.00+9.8% |
|
Aug 08
11:33 UTC
|
MFC
Manulife Financial
|
◎ Target | firm only | Outperform | C$55.00→ C$67.00+21.8% |
|
Aug 08
11:33 UTC
|
MFC
Manulife Financial
|
◎ Target | firm only | Buy | C$63.00→ C$68.00+7.9% |
|
Aug 08
11:33 UTC
|
MCHP
Microchip Technology
|
◎ Target | Atif Malik ★★★☆☆ #2088 | Buy | $113.00→ $95.00-15.9% |
|
Aug 08
11:33 UTC
|
MCHP
Microchip Technology
|
◎ Target | William Stein ★★☆☆☆ #2586 | Hold | $105.00→ $90.00-14.3% |
|
Aug 08
11:33 UTC
|
MARA
Marathon Digital
|
◎ Target | Brett Knoblauch ★☆☆☆☆ #3217 | Overweight | $14.00→ $12.00-14.3% |
|
Aug 08
11:33 UTC
|
LYFT
Lyft
|
◎ Target | Doug Anmuth ★★★☆☆ #1992 | Neutral | $18.00→ $19.00+5.6% |
|
Aug 08
11:33 UTC
|
LYFT
Lyft
|
◎ Target | Deepak Mathivanan ★★★☆☆ #1736 | Neutral | $14.00→ $17.00+21.4% |
|
Aug 08
11:33 UTC
|
LYFT
Lyft
|
◎ Target | Ken Gawrelski ★★★☆☆ #1080 | Equal Weight | $18.00→ $19.00+5.6% |
|
Aug 08
11:33 UTC
|
LYFT
Lyft
|
◎ Target | Stephen Ju ★★☆☆☆ #2324 | Neutral | $16.00→ $17.00+6.2% |
|
Aug 08
11:33 UTC
|
LYFT
Lyft
|
◎ Target | Brad Erickson ★★★☆☆ #1886 | Outperform | $18.00→ $20.00+11.1% |
|
Aug 08
11:33 UTC
|
LUN
Lundin Mining
|
◎ Target | firm only | Buy | C$43.00→ C$42.00-2.3% |
|
Aug 08
11:33 UTC
|
LSEG
London Stock Exchange Group
|
◎ Target | firm only | Buy | £129→ £127-1.6% |
|
Aug 08
11:33 UTC
|
LOCO
El Pollo Loco
|
◎ Target | Todd Brooks ★★★★☆ #723 | Buy | $18.00→ $21.00+16.7% |
|
Aug 08
11:33 UTC
|
LOAR
Loar
|
◎ Target | Ken Herbert not yet tracked | Outperform | $80.00→ $85.00+6.2% |
|
Aug 08
11:33 UTC
|
LNG
Cheniere Energy
|
◎ Target | Theresa Chen ★★★☆☆ #1703 | Overweight | $274.00→ $279.00+1.8% |
|
Aug 08
11:33 UTC
|
LLY
Eli Lilly and Company
|
◎ Target | Robyn Karnauskas not yet tracked | Buy | $1,370.00→ $1,376.00+0.4% |
|
Aug 08
11:33 UTC
|
LGND
Ligand Pharmaceuticals
|
◎ Target | Douglas Miehm ★★★☆☆ #1105 | Outperform | $340.00→ $345.00+1.5% |
|
Aug 08
11:33 UTC
|
LFST
LifeStance Health Group
|
◎ Target | David Larsen ★★★★☆ #512 | Buy | $15.00→ $16.00+6.7% |
|
Aug 08
11:33 UTC
|
LFMD
LifeMD
|
◎ Target | Yi Chen ★★☆☆☆ #2452 | Buy | $10.00→ $9.00-10.0% |
|
Aug 08
11:33 UTC
|
LEU
Centrus Energy
|
◎ Target | Sean Milligan ★☆☆☆☆ #3165 | Buy | $264.00→ $262.00-0.8% |
|
Aug 08
11:33 UTC
|
LEU
Centrus Energy
|
◎ Target | Bill Peterson ★★★☆☆ #1776 | Neutral | $178.00→ $180.00+1.1% |
|
Aug 08
11:33 UTC
|
LDOS
Leidos
|
◎ Target | Gautam Khanna ★★★☆☆ #1355 | Hold | $115.00→ $135.00+17.4% |
|
Aug 08
11:33 UTC
|
LAMR
Lamar Advertising
|
◎ Target | Alexey Philippov not yet tracked | Neutral | $153.00→ $160.00+4.6% |
|
Aug 08
11:33 UTC
|
KXS
Kinaxis
|
◎ Target | firm only | Outperform | C$195.00→ C$200.00+2.6% |
|
Aug 08
11:33 UTC
|
KXS
Kinaxis
|
◎ Target | firm only | Outperform | C$200.00→ C$210.00+5.0% |
|
Aug 08
11:33 UTC
|
KVYO
Klaviyo
|
◎ Target | Tyler Radke ★★★★☆ #373 | Buy | $34.00→ $36.00+5.9% |
|
Aug 08
11:33 UTC
|
KRMN
Karman
|
◎ Target | Austin Bohlig ★☆☆☆☆ #3142 | Buy | $125.00→ $80.00-36.0% |
|
Aug 08
11:33 UTC
|
KMP.UN
Killam Apartment REIT
|
◎ Target | firm only | Sec→ r Outperform | C$20.00→ C$20.25+1.2% |
|
Aug 08
11:33 UTC
|
KMP.UN
Killam Apartment REIT
|
◎ Target | firm only | Outperform | C$21.00→ C$21.25+1.2% |
|
Aug 08
11:33 UTC
|
KMP.UN
Killam Apartment REIT
|
◎ Target | firm only | Buy | C$21.00→ C$22.00+4.8% |
|
Aug 08
11:33 UTC
|
KHC
Kraft Heinz
|
◎ Target | Andrew Lazar ★★★☆☆ #1000 | Equal Weight | $25.00→ $26.00+4.0% |
|
Aug 08
11:33 UTC
|
KEY
Keyera
|
◎ Target | firm only | C$56.00→ C$61.00+8.9% | |
|
Aug 08
11:33 UTC
|
KDP
Keurig Dr Pepper
|
◎ Target | Peter Grom ★★★★★ #277 | Buy | $38.00→ $39.00+2.6% |
|
Aug 08
11:33 UTC
|
JHX
James Hardie Industries
|
◎ Target | Keith Hughes ★★★☆☆ #1495 | Buy | $30.00→ $40.00+33.3% |
|
Aug 08
11:33 UTC
|
JHX
James Hardie Industries
|
◎ Target | Trey Grooms ★★★☆☆ #1614 | Overweight | $33.00→ $34.00+3.0% |
|
Aug 08
11:33 UTC
|
JHX
James Hardie Industries
|
◎ Target | Tyler Batory ★★★☆☆ #1101 | Outperform | $32.00→ $36.00+12.5% |
|
Aug 08
11:33 UTC
|
JANX
Janux Therapeutics
|
◎ Target | Brad Canino not yet tracked | Buy | $58.00→ $55.00-5.2% |
|
Aug 08
11:33 UTC
|
ITT
ITT
|
◎ Target | Jeffrey Hammond ★★☆☆☆ #2566 | Overweight | $250.00→ $263.00+5.2% |
|
Aug 08
11:33 UTC
|
ITT
ITT
|
◎ Target | Vladimir Bystricky not yet tracked | Buy | $254.00→ $267.00+5.1% |
|
Aug 08
11:33 UTC
|
IRTC
iRhythm Technologies
|
◎ Target | Nathan Treybeck ★★★☆☆ #1268 | Overweight | $180.00→ $168.00-6.7% |
|
Aug 08
11:33 UTC
|
IRTC
iRhythm Technologies
|
◎ Target | David Saxon ★★★★★ #148 | Buy | $255.00→ $192.00-24.7% |
|
Aug 08
11:33 UTC
|
IRD
Opus Genetics
|
◎ Target | Lisa Walter ★★☆☆☆ #2754 | Outperform | $10.00→ $9.00-10.0% |
|
Aug 08
11:33 UTC
|
IOVA
Iovance Biotherapeutics
|
◎ Target | Etzer Darout ★★★☆☆ #1059 | Overweight | $11.00→ $13.00+18.2% |
|
Aug 08
11:33 UTC
|
IOVA
Iovance Biotherapeutics
|
◎ Target | Reni J. Benjamin not yet tracked | Market Outperform | $5.00→ $8.00+60.0% |
|
Aug 08
11:33 UTC
|
INVA
Innoviva
|
◎ Target | Steve Seedhouse not yet tracked | Overweight | $36.00→ $34.00-5.6% |
|
Aug 08
11:33 UTC
|
INSM
Insmed
|
◎ Target | Vamil Divan ★★★★☆ #904 | Buy | $207.00→ $205.00-1.0% |
|
Aug 08
11:33 UTC
|
INSM
Insmed
|
◎ Target | Benjamin Burnett ★★★☆☆ #1809 | Overweight | $161.00→ $169.00+5.0% |
|
Aug 08
11:33 UTC
|
IFRX
InflaRx
|
◎ Target | Steve Seedhouse not yet tracked | Overweight | $4.00→ $6.00+50.0% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.